[go: up one dir, main page]

AU4833385A - A synthetic signal sequence for the transport of proteins in expression systems - Google Patents

A synthetic signal sequence for the transport of proteins in expression systems

Info

Publication number
AU4833385A
AU4833385A AU48333/85A AU4833385A AU4833385A AU 4833385 A AU4833385 A AU 4833385A AU 48333/85 A AU48333/85 A AU 48333/85A AU 4833385 A AU4833385 A AU 4833385A AU 4833385 A AU4833385 A AU 4833385A
Authority
AU
Australia
Prior art keywords
transport
signal sequence
proteins
expression systems
synthetic signal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU48333/85A
Other versions
AU595486B2 (en
Inventor
Joachim Engels
Michael Leineweber
Eugen Uhlmann
Waldemar Wetekam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of AU4833385A publication Critical patent/AU4833385A/en
Application granted granted Critical
Publication of AU595486B2 publication Critical patent/AU595486B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

The DNA of a natural signal sequence is modified by incorporation of cleavage sites for endonucleases and is thus made suitable for incorporation in any desired vectors by the building block principle. The vectors modified in this way then bring about transport of the encoded protein out of the cytoplasm. <IMAGE>
AU48333/85A 1984-10-06 1985-10-04 A synthetic signal sequence for the transport of proteins in expression systems Expired AU595486B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19843436818 DE3436818A1 (en) 1984-10-06 1984-10-06 SYNTHETIC SIGNAL SEQUENCE FOR TRANSPORTING PROTEINS IN EXPRESSION SYSTEMS
DE3436818 1984-10-06

Publications (2)

Publication Number Publication Date
AU4833385A true AU4833385A (en) 1986-04-10
AU595486B2 AU595486B2 (en) 1990-04-05

Family

ID=6247347

Family Applications (1)

Application Number Title Priority Date Filing Date
AU48333/85A Expired AU595486B2 (en) 1984-10-06 1985-10-04 A synthetic signal sequence for the transport of proteins in expression systems

Country Status (15)

Country Link
EP (1) EP0177827B1 (en)
JP (1) JPS6188883A (en)
AT (1) ATE97445T1 (en)
AU (1) AU595486B2 (en)
CA (1) CA1340280C (en)
DE (2) DE3436818A1 (en)
DK (1) DK175511B1 (en)
ES (1) ES8605579A1 (en)
GR (1) GR852405B (en)
HU (1) HU197355B (en)
IE (1) IE63262B1 (en)
IL (1) IL76573A (en)
NZ (1) NZ213717A (en)
PH (1) PH30819A (en)
PT (1) PT81253B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0196864A3 (en) * 1985-03-25 1988-03-23 Cetus Corporation Alkaline phosphatase-mediated processing and secretion of recombinant proteins, dna sequences for use therein and cells transformed using such sequences
IT1196484B (en) * 1986-07-11 1988-11-16 Sclavo Spa YEAST EXPRESSION AND SECRETION VECTOR, USEFUL FOR THE PREPARATION OF HETEROLOGICAL PROTEINS
US5426036A (en) * 1987-05-05 1995-06-20 Hoechst Aktiengesellschaft Processes for the preparation of foreign proteins in streptomycetes
CA1314108C (en) * 1988-03-18 1993-03-02 Robert P. Ryan Distributed reference and change table for a virtual memory system
EP1613159A4 (en) 2003-03-27 2007-08-01 Ptc Therapeutics Inc Methods of identifying compounds that target trna splicing endonuclease and uses of said compounds as anti-fungal agents
EP2319318A3 (en) 2003-03-27 2011-08-17 PTC Therapeutics, Inc. Methods of identifying compounds that target TRNA splicing endonuclease and uses of said compounds as anti-proliferative agents
JP4990621B2 (en) 2003-07-02 2012-08-01 ピーティーシー セラピューティクス，インコーポレーテッド RNA processing protein complex and use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5939899A (en) * 1982-08-27 1984-03-05 Gakuzo Tamura Novel vector
US4711844A (en) * 1983-03-09 1987-12-08 Cetus Corporation Modified signal peptides
NZ207925A (en) * 1983-04-25 1988-05-30 Genentech Inc Yeast expression vehicle consisting of a yeast promoter and signal peptide encoding region linked to a heterologus peptide coding region; expression and culture
US4663280A (en) * 1983-05-19 1987-05-05 Public Health Research Institute Of The City Of New York Expression and secretion vectors and method of constructing vectors
AU3011684A (en) * 1983-05-19 1984-12-04 Public Health Research Institute Of The City Of New York, Inc., The Expression and secretion vectors & method of constructing vectors
JPS6030687A (en) * 1983-08-01 1985-02-16 Wakunaga Seiyaku Kk Dna gene, its preparation and plasmid containing the same
EP0170266B1 (en) * 1984-07-30 1993-03-24 Wakunaga Seiyaku Kabushiki Kaisha Process for producing protein, and vector, recombinant dna and transformant used therefor

Also Published As

Publication number Publication date
DE3436818A1 (en) 1986-04-10
DK175511B1 (en) 2004-11-15
IE63262B1 (en) 1995-04-05
ES8605579A1 (en) 1986-03-16
CA1340280C (en) 1998-12-22
HU197355B (en) 1989-03-28
EP0177827A2 (en) 1986-04-16
PT81253B (en) 1987-11-30
PH30819A (en) 1997-10-17
IL76573A (en) 1992-06-21
AU595486B2 (en) 1990-04-05
EP0177827A3 (en) 1987-12-02
GR852405B (en) 1986-02-04
EP0177827B1 (en) 1993-11-18
JPS6188883A (en) 1986-05-07
DK453285A (en) 1986-04-07
HUT40164A (en) 1986-11-28
ES547600A0 (en) 1986-03-16
ATE97445T1 (en) 1993-12-15
NZ213717A (en) 1989-01-06
IE852440L (en) 1986-04-06
DE3587660D1 (en) 1993-12-23
PT81253A (en) 1985-11-01
DK453285D0 (en) 1985-10-04
IL76573A0 (en) 1986-02-28

Similar Documents

Publication Publication Date Title
AU573523B2 (en) Functional human urokinase proteins
ATE44768T1 (en) PROCESS FOR THE MICROBIOLOGICAL PREPARATION OF HUMAN SERUM ALBUMIN.
AU579323B2 (en) Vaccines based on membrane bound proteins and process for making them
IL90436A0 (en) Protein crosslinking reagents cleavable within acidified intracellular vesicles
AU544453B2 (en) Bovine pre-growth and growth hormone
FI91160B (en) Process for the preparation of modified human t-PA protein
DE3677685D1 (en) SIGNAL ENCODING METHOD AND FOR CARRYING OUT THIS METHOD.
AU592791B2 (en) Recombinant DNA expression vectors and DNA compounds which encode isopenicillin N synthetase
AU4833385A (en) A synthetic signal sequence for the transport of proteins in expression systems
AU4749685A (en) Mutual separation of proteins
AU3751689A (en) Vector for secretion of proteins directly into periplasm or culture medium
AU4257789A (en) Electro-insertion of proteins into animal cell membranes
FI896261A7 (en) Method for producing a protein or polypeptide, DNA sequence encoding the polypeptide, microorganism containing the DNA sequence and polypeptide and its use as a pharmaceutical preparation
GR3006045T3 (en)
GB2212502B (en) Monoclonal antibody against membrane cytoskeleton proteins
AU3846285A (en) Protein concentrate
BG51941B2 (en) Method for the preparation of hydrolysate protein concentrate